Literature DB >> 11914214

Limited macular translocation with scleral retraction suture.

P Sullivan1, L Filsecker, J Sears.   

Abstract

BACKGROUND/AIMS: Macular translocation with scleral imbrication is a new technique for treating subfoveal choroidal neovascular membranes (CNV). This procedure shortens the sclera but may result in a minimal decrease in the internal circumference of the globe and limits the amount of foveal displacement. The authors propose a new scleral retraction suture aimed at decreasing the internal circumference of the globe in an effort to increase foveal displacement.
METHODS: Using a cadaver model, they compared the amount of scleral shortening using a standard scleral imbrication technique and a modified three suture scleral retraction technique. Sections of the globes were digitised and specialised software was used to estimate the amount of scleral shortening. Three patients with subfoveal choroidal neovascularisation underwent limited macular translocation using pars plana vitrectomy and macular detachment with the modified scleral suture technique. The main outcome measures were visual acuity, foveal displacement, and complications.
RESULTS: In the cadaver model, the scleral retraction suture resulted in a flatter internal scleral fold compared to the standard suture technique and created approximately 890 microm of effective scleral shortening. In the patients who underwent macular translocation and laser photocoagulation of the CNV, visual acuity improved in two patients and worsened in one patient. The range of foveal displacement was 1400-2400 microm.
CONCLUSION: The foveal displacements achieved in this limited study compared to median displacement previously published using standard suture techniques demonstrates that the scleral retraction suture technique may be a useful adjunct to limited macular translocation. The advantage of this type of suture in conjunction with translocation may depend on the effective scleral shortening offered by this retraction suture.

Entities:  

Mesh:

Year:  2002        PMID: 11914214      PMCID: PMC1771107          DOI: 10.1136/bjo.86.4.434

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  28 in total

1.  Effective macular translocation without scleral imbrication.

Authors:  E de Juan; J F Vander
Journal:  Am J Ophthalmol       Date:  1999-09       Impact factor: 5.258

2.  Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Authors:  D J Pieramici; E De Juan; G Y Fujii; S M Reynolds; M Melia; M S Humayun; A P Schachat; C D Hartranft
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

3.  Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1.

Authors:  N M Bressler; S B Bressler; B S Hawkins; M J Marsh; P Sternberg; M A Thomas
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

4.  Macular translocation with retinotomy and retinal rotation for exudative age-related macular degeneration.

Authors:  L Akduman; M P Karavellas; J C MacDonald; R J Olk; W R Freeman
Journal:  Retina       Date:  1999       Impact factor: 4.256

5.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1999-10

6.  The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975.

Authors:  H M Leibowitz; D E Krueger; L R Maunder; R C Milton; M M Kini; H A Kahn; R J Nickerson; J Pool; T L Colton; J P Ganley; J I Loewenstein; T R Dawber
Journal:  Surv Ophthalmol       Date:  1980 May-Jun       Impact factor: 6.048

7.  Scleral outfolding for macular translocation.

Authors:  S B Lin; B M Glaser; D Gould; T A Baudo; R R Lakhanpal; R P Murphy
Journal:  Am J Ophthalmol       Date:  2000-07       Impact factor: 5.258

8.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

Authors: 
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

9.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

Authors:  N M Bressler
Journal:  Arch Ophthalmol       Date:  2001-02

10.  Age-related macular degeneration and blindness due to neovascular maculopathy.

Authors:  F L Ferris; S L Fine; L Hyman
Journal:  Arch Ophthalmol       Date:  1984-11
View more
  1 in total

1.  Redistribution of the neurosensory retina in inferior limited macular translocation: an evaluation using image registration.

Authors:  Eric Denion; John-Richard Ordonez; Jean-Claude Klein; Agnès Glacet-Bernard; Thomas Walter; Georges Caputo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-31       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.